[¹²³I/¹²⁵I]-RO 43-0463, A site specific tracer for MAO-B mapping with autoradiography as well as with spet

References

• Haefely W. E., Kettler R., Keller H. H., Da Prada M. Ro 19-6327, a reversible and highly selective monoamino oxidase B inhibitor: a novel tool to explore the MAO-B function in humans. Advances in Neurolgy, Vol. 53: Parkinson's Disease: Anatomy, Pathology, and Therapy, M. B. Streifler, A. D. Korczyn, E. Melamed, M. B.H. Youdim. Raven Press, New York 1990; 505–512
   Google Scholar
• Kyburz E. New developments in the field of MAO inhibitors. Drug News and Perspectives 1990; 3: 592–599
   Google Scholar
• Richards G., Saura J., Ulrich J., Da Prada M. Molecular neuroanatomy of monoamine oxidase in human brainstem. Psychopharmacology 1992; 106: 21–23
   Google Scholar
• Strohlin-Benedetti M., Dostert Ph. Monoamine oxidase. brain aging and degenerative diseases. Biochem. Pharmacol. 1989; 38: 555–561
   Google Scholar
• Oreland L., Gottfries C. D. Brain monoamine oxidase in aging and in dementia of Alzheimer type. Prog. Neuropsychopharmacol. Biol. Psychiatr. 1986; 10: 533–540
   Google Scholar
• Jossan S. S., Gilberg P.-G., Karlsson I., Gottfries C. D., Oreland L. Visualization of brain monoamine oxidase B (MAO-B) in dementia of Alzheimer's type by means of large cryosection autoradiography; a pilot study. J. Neurotransm. 1990; 32: 61–66
   Google Scholar
• Parkinson study group. Effect of deprenyl on the progression of disability in early Parkinson's disease. N. Engl. J. Med. 1989; 321: 1364–1371
   PubMed Web of Science ®Google Scholar
• Parkinson study group. DATATOP: a multicenter controlled clinical trial in early Parkinson's disease. Arch. Neurol. 1989; 46: 1052–1060
   PubMed Web of Science ®Google Scholar
• Bench C. J., Price G. W., Lammertsma A. A., Cremer J. C., Luthra S. K., Turton D., Dolan R. J., Kettler R., Dingemanse J., Da Prada M., Biziere K., McClelland G. R., Jamieson V. L., Wood N. D., Frackowiak R. S.J. Measurement of human cerebral monoamine oxidase type B (MAO-B) activity with positron emission tomography (PET): a dose ranging study with the reversible inhibitor Ro 19-6327. Eur. J. Clin. Pharmacol. 1991; 40: 169–173
   PubMed Web of Science ®Google Scholar
• Da Prada M., Kettler R., Keller H. H., Burkard W. P. Ro 19-6327, a reversible, highly, selective inhibitor of type B monoamine oxidase, completely devoid of tyramine-potentiating effects: comparison with selegiline. Progress in catecholamine research, Part B: Central aspects. Alan R. Liss. 1988; 359–363
   Google Scholar
• MacWhorter S. E., Baldwin R. M. Synthesis and biodistribution of 123I N-(2-aminoethyl)-5-iodo-2-pyridinecarboxamide (Ro 43-0463). a monoamine oxidase B inhibitor. Nucl. Med. Biol. 1991; 18: 563–564
   Google Scholar
• Beer H.-F., Sha L., Novak-Hofer I., Bläuenstein P., Schubiger P. A. Large scale preparation strategy for labelling of [123I]-SCH 23982. a dopamine D1 receptor binding agent. Appl. Radiat. Isot. 1992; 46: 781–787
   Google Scholar
• Kettler R., Dr. Hoffmann-La Roche. Basle CH, Personal communication from
   Google Scholar
• Cesura A. M., Galva M. D., Imhof R., Kyburz E., Picotti G. B., Da Prada M. [3H]-Ro 19-6327: a reversible ligand and affinity labelling probe for monoamine oxidase-B. Eur. J. Pharmacol. 1989; 162: 457–465
   Google Scholar
• Wyss R., Philipp W. Determination of the monoamine oxidase B inhibitor Ro 19-6327 in plasma by high-performance liquid chromatography using precolumn derivatization with fluorescamine and fluorescence detection. J. Chrom. 1990; 507: 187–198
   Google Scholar
• Winchell H. S., Baldwin R. M., Lin T. H. Development of I-123-labeled amines for brain studies: localization of I-123-iodophenylalkyl amines in rat brain. J. Nucl. Med. 1980; 21: 940–946
   PubMedGoogle Scholar
• Berman M., Braverman L. E., Burke J., De Groot L., McCormack K. R., Oddie T. H., Rohrer R. H., Wellman H. N., Smith E. M. MIRD/dose estimate report No. 5, summary of current radiation dose estimates to humans from 123I, 124I, 125I, 126I, 130I, 131I, and 132I as sodium iodide. J. Nucl. Med. 1975; 16: 857–860
   Google Scholar
• Hasler P. H., Beer H.-F., Frey L. D., Rosetti I., Schubiger P. A. Biodistribution and Estimated Radiation Burden for a New I-123 Labelled Monoamine Oxidase-B Inhibitor (Ro 43-0463). J. Nucl. Biol. Med., accepted
   Google Scholar
• Saura M. J., Kettler R., Da Prada M., Richards G. Molecular neuroanatomy of MAO-A and MAO-B. J. Neural Transm. 1990; 32: 49–53
   Google Scholar
• Saura J., Kettler R., Da Prada M., Richards J. G. Quantitative enzyme radioautography with 3H-Ro 41-1049 and 3H-Ro 19-6327 in vitro: Localization and Abundance of MAO-A and MAO-B in rat CNS, peripheral organs, and human brain. J. Neuroscience 1992; 12: 1977–1999
   PubMed Web of Science ®Google Scholar